These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 15172010)

  • 1. Origins, practices and future of safety pharmacology.
    Bass A; Kinter L; Williams P
    J Pharmacol Toxicol Methods; 2004; 49(3):145-51. PubMed ID: 15172010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Historical View and Vision into the Future of the Field of Safety Pharmacology.
    Bass AS; Hombo T; Kasai C; Kinter LB; Valentin JP
    Handb Exp Pharmacol; 2015; 229():3-45. PubMed ID: 26091634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety pharmacology: an essential interface of pharmacology and toxicology in the non-clinical assessment of new pharmaceuticals.
    Claude JR; Claude N
    Toxicol Lett; 2004 Jun; 151(1):25-8. PubMed ID: 15177637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety pharmacology and risk assessment.
    Kinter LB; Valentin JP
    Fundam Clin Pharmacol; 2002 Jun; 16(3):175-82. PubMed ID: 12165065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges and lessons learned since implementation of the safety pharmacology guidance ICH S7A.
    Valentin JP; Bass AS; Atrakchi A; Olejniczak K; Kannosuke F
    J Pharmacol Toxicol Methods; 2005; 52(1):22-9. PubMed ID: 15961324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety pharmacology in the nonclinical assessment of new medicinal products: definition, place, interest and difficulties.
    Claude JR
    Fundam Clin Pharmacol; 2002 Apr; 16(2):75-8. PubMed ID: 12031059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality management of pharmacology and safety pharmacology studies.
    Spindler P; Seiler JP
    Fundam Clin Pharmacol; 2002 Apr; 16(2):83-90. PubMed ID: 12031061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of in vitro methods to safety pharmacology.
    Wakefield ID; Pollard C; Redfern WS; Hammond TG; Valentin JP
    Fundam Clin Pharmacol; 2002 Jun; 16(3):209-18. PubMed ID: 12165068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods in safety pharmacology in focus.
    Pugsley MK; Gallacher DJ; Towart R; Authier S; Curtis MJ
    J Pharmacol Toxicol Methods; 2008; 58(2):69-71. PubMed ID: 18707009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methodological innovations expand the safety pharmacology horizon.
    Pugsley MK; Curtis MJ
    J Pharmacol Toxicol Methods; 2012 Sep; 66(2):59-62. PubMed ID: 22617368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Conference on Harmonisation; guidance on S7A safety pharmacology studies for human pharmaceuticals; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Jul; 66(135):36791-2. PubMed ID: 12356097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety pharmacology in focus: new methods developed in the light of the ICH S7B guidance document.
    Pugsley MK; Curtis MJ
    J Pharmacol Toxicol Methods; 2006; 54(2):94-8. PubMed ID: 16806993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissions.
    Ewart L; Milne A; Adkins D; Benjamin A; Bialecki R; Chen Y; Ericsson AC; Gardner S; Grant C; Lengel D; Lindgren S; Lowing S; Marks L; Moors J; Oldman K; Pietras M; Prior H; Punton J; Redfern WS; Salmond R; Skinner M; Some M; Stanton A; Swedberg M; Finch J; Valentin JP
    J Pharmacol Toxicol Methods; 2013; 68(1):30-43. PubMed ID: 23665080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of some pharmacological methods used in safety pharmacology studies.
    Pugsley MK
    Proc West Pharmacol Soc; 2004; 47():18-22. PubMed ID: 15633602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolites in safety testing.
    Robison TW; Jacobs A
    Bioanalysis; 2009 Oct; 1(7):1193-200. PubMed ID: 21083045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory aspects of oncology drug safety evaluation: past practice, current issues, and the challenge of new drugs.
    Rosenfeldt H; Kropp T; Benson K; Ricci MS; McGuinn WD; Verbois SL
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):125-33. PubMed ID: 20045015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodology used in safety pharmacology: appraisal of the state-of-the-art, the regulatory issues and new directions.
    Pugsley MK
    J Pharmacol Toxicol Methods; 2005; 52(1):1-5. PubMed ID: 15982903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for the no observed adverse effect level in safety pharmacology?
    Mow T; Andersen NK; Dragsted N; Lassen AB; Laursen M; Bass AS; Valentin JP; Markgraf C; Authier S; Baird TJ; Bhatt S; Traebert M; Leishman DJ; Jones D; Curtis MJ
    J Pharmacol Toxicol Methods; 2020 Sep; 105():106917. PubMed ID: 32866658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular pressure, contractility and dP/dt(max) in nonclinical drug safety assessment studies.
    Sarazan RD; Kroehle JP; Main BW
    J Pharmacol Toxicol Methods; 2012 Sep; 66(2):71-8. PubMed ID: 22659561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.